Clinical Trials Sponsored by Invatec S.p.A.
Total 770 results
-
Chiesi Farmaceutici S.p.A.TerminatedNeonatal Opioid Withdrawal SyndromeUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedSevere Combined Immunodeficiency | Adenosine Deaminase DeficiencyUnited States
-
Chiesi Farmaceutici S.p.A.Active, not recruitingFabry DiseaseUnited States, Netherlands, Australia, Hungary, United Kingdom, Canada, Czechia, Finland, France, Italy, Norway, Slovenia, Spain
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBulgaria
-
Chiesi Farmaceutici S.p.A.WithdrawnRestoration of Function to CVADsUnited States, Bulgaria, Hungary
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseFrance
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly, Germany, Hungary
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedRespiratory Distress Syndrome, NewbornUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Fidia Farmaceutici s.p.a.Completed
-
Dompé Farmaceutici S.p.ACompletedPancreatic Islet Transplantation in Type 1 Diabetes MellitusItaly, Germany
-
Fidia Farmaceutici s.p.a.CompletedONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.Non-Invasive Papillary Carcinoma of BladderSpain, Germany, Italy
-
ClinedemAlfasigma S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedAsthmaSpain, Austria, Italy, Poland
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedCystic FibrosisCzechia, Moldova, Republic of, Slovakia
-
Chiesi Farmaceutici S.p.A.CompletedCystic FibrosisUkraine, France, Poland
-
Chiesi Farmaceutici S.p.A.CompletedA Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 (CHF6001Ext)Chronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Fidia Farmaceutici s.p.a.Completed
-
Fidia Farmaceutici s.p.a.CompletedVulvovaginal AtrophySlovakia
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium, Hungary
-
AGC Biologics S.p.A.Completed
-
AGC Biologics S.p.A.CompletedMalignant Pleural MesotheliomaItaly
-
AGC Biologics S.p.A.Completed
-
Dompé Farmaceutici S.p.ACompleted
-
Dompé Farmaceutici S.p.ACompletedEarly Allograft Dysfunction | Ischemia-reperfusion Injury in Liver TransplantBelarus, Russian Federation
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedBronchial AsthmaSpain, Italy, Russian Federation, Ukraine
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly
-
Chiesi Farmaceutici S.p.A.CompletedCOPDUnited Kingdom, Ireland